Tools
ToolsAlexandre, L., Broughton, T., Loke, Y. and Beales, I. L. P. (2012) Meta-analysis: Risk of esophageal adenocarcinoma with medications which relax the lower esophageal sphincter. Diseases of the Esophagus, 25 (6). pp. 535-544. ISSN 1442-2050
Full text not available from this repository. (Request a copy)Abstract
Reasons for the rising annual incidence of esophageal adenocarcinoma (EAC) remain uncertain. Previous studies have given conflicting results, but some have suggested that drugs which relax the lower esophageal sphincter (LES) may increase the risk of EAC. This study is to determine systematically the risk of EAC associated with individual medications which relax the LES and compare risks with esophageal squamous cell carcinoma (ESCC) and gastric cardia adenocarcinoma (GCA). Relevant published studies were identified by systematic searching PubMed for case-control studies reporting on risk of EAC, ESCC or GCA with use of medications known to reduce LES pressure. Pooled odds ratios (ORs) were calculated for each malignancy. Data were analyzed from four case-control studies involving 9,412 participants. EAC was significantly associated with theophylline use (OR 1.55, 95% confidence interval [CI] 1.05-2.28; P= 0.03, I(2) = 0%) and anticholinergic medications (OR 1.66, 95% CI 1.13-2.44; P= 0.01, I(2) = 84%). This effect was not observed in cases of ESCC or GCA. Other drug groups including calcium channel modulators and nitrates did not increase the risk of EAC. An inverse relationship was observed between ESCC and nitrates and between GCA and benzodiazepines. The lack of increased EAC risk with many commonly used medications is reassuring. However, a significant correlation was found between EAC and the use of anticholinergics and theophyllines. This may reflect common causality between obstructive lung disease and EAC, and further studies to explore these relationships are warranted.
| Item Type: | Article |
|---|---|
| Additional Information: | © 2011 Copyright the Authors. Journal compilation © 2011, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus. |
| Uncontrolled Keywords: | adenocarcinoma,adrenergic beta-agonists,benzodiazepines,calcium channel blockers,carcinoma, squamous cell,cardia,cholinergic antagonists,esophageal neoplasms,esophageal sphincter, lower,humans,nitric oxide donors,odds ratio,risk,risk factors,stomach neoplasms,theophylline,vasodilator agents |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health |
| Depositing User: | Rhiannon Harvey |
| Date Deposited: | 22 Feb 2012 14:36 |
| Last Modified: | 06 Jun 2024 14:36 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/37382 |
| DOI: | 10.1111/j.1442-2050.2011.01285.x |
Actions (login required)
 |
View Item |